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Abstract
Background: Many commonly used xenograft tumor models do not spontaneously metastasize to distant organs
following subcutaneous or orthotopic implantation, limiting their usefulness in preclinical studies. It is generally
believed that natural killer cells are the key component of the innate immune system in determining tumor metastatic
potential in xenograft models. However, recent studies suggest that macrophages may play an important role, as
resident macrophages can eliminate the invading tumor cells if they do not express adequate levels of the CD47
molecule.
Methods: We investigated the effect of overexpressing murine CD47 (mCD47) in PC-3 cells, a commonly used
human prostate cancer line, on the metastatic potential in three mouse strains with different genetic background
and varying degrees of immunodeficiency. We implanted the tumor cells either subcutaneously or orthotopically
and then examined their local and distant metastases.
Results: Our results show that mCD47-expressing PC-3 cells subcutaneously implanted in NSG and CB17. Scid
mice metastasized to the sentinel lymph node, lung and liver significantly more efficiently than the control cells.
When implanted orthotopically to NOD. Scid mice, these cells spontaneously metastasized to lung and liver.
Conclusions: Our data demonstrate that mCD47 can facilitate human tumor cell metastasis in murine models,
and that these mCD47-expressing tumor cells may be useful for in vivo studies where spontaneous metastases
are desirable.
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Background
Xenografted tumor models are frequently used in cancer
research, particularly for the purpose of evaluating experi-
mental therapeutics. However, many of the commonly
used xenograft tumor models do not spontaneously
metastasize to other organ tissues after subcutaneous or
orthotopic implantation [1]. This has diminished their
usefulness in preclinical studies. Take prostate cancer as
an example, many human prostate cancer cell lines have
been established from patients [2]. Although most of them
were primarily obtained from metastatic deposits, they
usually exhibit a deficient metastatic behavior when
implanted in immunodeficient mice [2]. Attempts to
improve the metastatic potential of the commonly used
prostate cancer cell lines seem to have only achieved a
moderate success. For example, a few sublines with in-
creased metastatic potential have been isolated from the
PC-3 M and LNCaP human prostate cancer cells through
multiple rounds of implanting these tumor cells intrapros-
tatically followed by harvesting tumor tissues from the
draining lymph nodes [3]. Although some of these sub-
lines (e.g. PC-3 M-LN4) produced higher incidence of
lung and bone metastasis after intravenous or intracardiac
inoculation, they did not show significant enhancement
over the parental line on spontaneous metastasis after
orthotopic implantation [3].
Spontaneous cancer metastasis is a multi-step process,
in which the tumor cells in their primary site initially be-
come detached from the local tumor tissue. The detached
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tumor cells subsequently enter into either blood or
lymphatic circulation, which is followed by extravasation
into the distant organ tissue. After arriving in the paren-
chyma of the secondary organ, the tumor cells need to
adapt to the new environment to reinitiate their growth
for the eventual formation of micrometastases [4]. Studies
have suggested that interaction of the arrived tumor cells,
the “seeds”, with the local tissues of the metastatic site, the
“soils”, is a complex process [5]. For example, some stud-
ies have suggested that primary tumors may release sys-
temic signals to allow establishment of specific niches at
the metastatic site to accommodate the metastatic pro-
pensity of the extravasated tumor cells [6, 7]. Other stud-
ies have shown that the arrived tumor cells can actively
adapt to the new tissue microenvironment at the meta-
static site by altering their gene expression such as activa-
tion of the Src tyrosine kinase signaling [8]. More recent
studies have suggested that local macrophages may be an
important “soil” component in dictating the ability of the
arrived tumor cells to form metastatic tumor, as the resi-
dent macrophages have the capability to eliminate the in-
vading tumor cells if they do not express an adequate level
of the “don’t eat me” signal – the CD47 molecule [9–11].
In this study, we investigated the effect of overexpress-
ing murine CD47 (mCD47) in the commonly used PC-3
human prostate cancer cell line on its metastatic poten-
tial in murine models. CD47 is a membrane protein and
the ligand for SIRPα, a receptor expressed on phagocytic
cells such as macrophages [11]. The binding of CD47 to
SIRPα results in the inhibition of macrophage-mediated
scavenging and phagocytosis, which renders CD47 the
moniker of “don’t eat me” signal [12]. We hypothesized
that overexpression of mCD47 would allow human can-
cer cells to escape detection and elimination by macro-
phages and possibly some other phagocytes, which are
largely intact in immune deficient mice used for xeno-
grafted tumor models. This should allow the xenografted
tumor cells to grow better with more efficient metastasis in
murine models. We tested our hypothesis in three mouse
strains with a varying degree of immunodeficiency and dif-
ferent genetic background. Our results show that mCD47-
expressing PC-3 cells implanted on the flank of NSG mice
were able to metastasize to the sentinel lymph nodes, lung
and liver in a significantly greater extent than the control
cell lines. When implanted orthotopically to the NOD.Scid
mice, the mCD47-expressing PC-3 cells spontaneously me-
tastasized to lungs and livers more efficiently and formed
larger tumors when compared with the control PC-3 and
PC-3 M-LN4 cells. Similar results were obtained with the
cells implanted in CB17.Scid mice. Our data thus demon-
strate that overexpression of mCD47 can enhance human
tumor cell metastasis in murine models, and that these
mCD47-expressing tumor cells can be useful for in vivo
studies where spontaneously metastases are desirable.
Methods
Cancer cell lines and cultures
The human prostate cancer cell line PC-3 (derived from a
bone metastasis), the human colon cancer cell line
HCT116 and the immortalized murine macrophage cell
line RAW 264.7 were obtained from the American Type
Culture Collection (Manassas, VA). The PC-3 M-LN4, a
PC-3 variant, was kindly provided by Dr. Isaiah J. Fidler
(M. D. Anderson Cancer Center, Houston, TX). PC-3 cells
were grown in complete RPMI 1640 medium supple-
mented with 20 mM HEPES, 2 mM L-glutamine, 10,000
U.I./mL penicillin-streptomycin, 1 mM sodium Pyruvate,
1 % MEM non-essential amino acids (Life Technologies,
Grand Island, NY), and 10 % FBS (Fetal Bovine Serum,
Gemini Bio-Products, West Sacramento, CA). HCT116
cells were grown in 10 % DMEM and 1 % penicillin-
streptomycin. RAW 264.7 cell were cultured in DMEM
containing 10 % heat-inactivated FBS and 1 % penicillin-
streptomycin. Cells were cultured at 37 °C in a 5 % CO2
water saturated atmosphere.
Generation of CD47-containing vectors for establishing
stable cell lines
The murine CD47 coding sequence (GenBank: Z25524.1)
was synthesized by Integrated DNA Technologies
(Coralville, IA), and cloned into the mammalian expres-
sion vector pIR-PURO. A fusion gene of GFP and lucifer-
ase, which was generated in our own lab, was also cloned
into the same pIR-PURO plasmid (Fig. 1). The details of
plasmid pCMVpiggyBAC have been described elsewhere
[13]. It was transfected together with pIR-GFP-Luc or
pIR-PURO-mCD47 (Fig. 1a) into either PC-3 or HCT116
cells, using Lipofectamine 2000 and Opti-MEM (Life
Technologies, Grand Island, NY). Puromycin was added
to transfected cells 48 h later at a concentration of 1 μg/
mL, which was gradually increased up to 3 μg/mL for two
weeks, as previously described for resistant-cell selection
(Rivera et al., 2011).
Flow cytometric analysis and cell sorting
The puromycin-resistant, GFP-, and CD47-expressing
PC-3 cells were labeled for FACS analysis (GFP and CD47
double positive cells) with either a rat PE Rat IgG2a, κ
isotype control antibody (cat # 400507, Biolegend CA) or
a rat PE anti mouse CD47 antibody (Cat # 127507, Biole-
gend). For live sorting, a concentration of ≤1.0 μg per
million cells in 100 μl volume was used. Cells were incu-
bated for 30 min at 4 °C in the dark in a PBS solution con-
taining 2 % FBS plus either the isotype or the mCD47
antibody. Cells then were washed twice with the same
solution. FACS analysis was performed on a Beckton
Dickinson FACSAria (BD Biosciences, San Jose, CA).
Gates were established with unstained cells operating at
low pressure (20 psi) using a 100 μm nozzle. Cell clusters
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and doublets were electronically gated out. Cells were rou-
tinely double-sorted using GFP and PE, and post-sort ana-
lysis typically indicated purities of > 90 % with minimal
cell death (<10 %). Total viable cells were used for the fol-
lowing experiments.
Phagocytosis assay
For the in vitro phagocytosis assay, Raw 264.7 cells
were first activated with 50U/ml of murine IFNγ and
10 ng/ml of LPS for 24 h. The cells were then plated
into a 96-well at 1 × 105 per well along with 2 × 104
cancer cells. The next day, phagocytosis was verified by
the luciferase assay using the Bright-Glo™ Luciferase
Assay System (cat # E2610, Promega, Madison, WI) ac-
cording to the manufacture’s instruction. Briefly, wells
were rinsed with PBS; after that, 200 μl of a 1:1 mix of
PBS plus Bright-Glo reagent were poured into each
well, mixed with the cells and then luciferase activity
was measured in a Victor X4 Multilabel Plate Reade
spectrophotometer (Perkin Elmer, Waltham MA).
Animal studies
All animal husbandry and experimental procedures con-
ducted in this study were approved by the University of
Houston Institutional Animal Care and Use Committee
(IACUC). Six-week-old male NOD.Cg-PrkdcscidIl2rgtm1Wjl/
SzJ mice or NSG mice, NOD.CB17-Prkdcscid/J or
NOD.Scid mice (The Jackson Laboratory, Bar Harbor,
ME), and C.B-Igh-1b/IcrTac-Prkdcscid or CB17.Scid (Taconic,
Germantown, NY) were used in this study. The stable hu-
man prostate cancer cell lines PC-3 expressing either
mCD47-GFP-Luc (PC3-mCD47) or GFP-Luc (PC3-GFP-
Luc) were implanted subcutaneously into the mouse right
flank in a concentration of 2 × 106 cells. PC3-mCD47,
PC3-GFP-Luc or PC-3 M-LN4 were implanted orthotopi-
cally in a concentration of 2 × 104 cells.
Tumors implanted subcutaneously were let grow for up
to 3 or 4 weeks or until they reached approximately
1500 mm3 and then excised. Tumor growth was moni-
tored every 3 days by measuring two perpendicular tumor
diameters with a caliper, and their volume was calculated
by the formula ½ (Length ×Width2). For the orthotopic
model, each mouse received intraprostatic injections of
PC3-mCD47, PC3-GFP-Luc or PC-3 M-LN4. Biolumines-
cent imaging was done weekly for a month to quantitate
the luciferase signal from PC3-mCD47 and PC3-GFP-Luc
cells as described in more detail in the following section.
Mice were sacrificed after that, lungs and livers were
Fig. 1 Construction and expression of mCD47. a Schematic illustration of mCD47-GFP-Luc and GFP-Luc in a transposon vector construct. The coding
sequences for murine CD47 (mCD47) or GFP-luciferase fusion gene (GFP-Luc) are shown. The locations of the promoter, the polyA signal, and the
internal ribosome entry site (IRES) are indicated. b Transfection efficiency of mCD47. PC-3 cells were transfected with a Piggyback transposon with
mCD47- GFP-Luc or GFP-Luc vectors, or mock transfected. Following puromycin selection, cells were stained with an isotype or a PE-conjugated
anti-mCD47 antibody, and then analyzed by flow cytometry for detection of PE and GFP
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harvested and metastatic lesions on these organs were
counted after H&E staining.
For in vivo imaging, mice were fed on alfalfa-free rodent
food (Teklad Global irradiated Soy Protein-Free Extruded
Rodent Diet Cat # 2920X, Harlan Laboratories, Madison
WI) two weeks prior and during imaging. After tumor
excision, weekly observation of the luciferase activity
was performed sequentially for a month using an IVIS
Spectrum Pre-clinical in vivo Imaging System (Perkin
Elmer, Waltham MA). Mice were injected intraperito-
neally with 150 mg/kg D-luciferin (cat # LUCK-1G,
Gold Biotechnology, St. Louis, MO) dissolved in water.
Bioluminescence images were taken 5–10 min after the
luciferin injection. A negative control mouse injected
with luciferin was placed next to treated animals during
each image acquisition to provide a constant reference
for the background. Images were analyzed using Living
Image version 4.2 software (Perkin Elmer) and repre-
sented as total flux measurements in photons/second.
For histological staining, organ tissues including lungs
and livers were collected and fixed in 10 % formalin. Serial
5-μm cross-sections of pulmonary and hepatic metastases
from mice implanted with either PC3-mCD47 or PC3-
GFP-Luc cells were prepared and H&E stained for exam-
ination with light microscopy. Five fields of each single
representative section were examined for each organ from
each of the five mice in each group using an Olympus
BX51 microscope, a camera Olympus DP73, and its asso-
ciated software, Olympus cellSens® 1.9 (Olympus Imaging
America Inc., Center Valley, PA).
Statistical analysis
All quantitative data are reported as mean ± SD. Statis-
tical analysis was made for multiple comparisons using
analysis of variance and Student’s t-test. p value <0.05
was considered to be statistically significant.
Results
Establishment and characterization of mCD47-expressing
PC-3 cells
The coding sequence for murine CD47 was synthesized
according to GenBank (Z25524.1), and cloned into the
transposon vector pIR-PURO [14]. To facilitate in vitro
and in vivo characterization, a fusion gene of GFP lucifer-
ase (GFP-Luc) was included in all the transposon vectors,
with the control vector containing GFP-Luc only. The de-
tailed composition of these transposon vectors is depicted
in Fig. 1a. To ensure that the established cells overexpress
the transgenes, pIR-mCD47-GFP-Luc or pIR-GFP-Luc
was co-transfected with pCMVpiggyBAC [13]. The piggy-
Bac transposase expressed from pCMVpiggyBAC would
allow the transgenes contained in the transposon donor
plasmids to be efficiently integrated into the chromosomes
of PC-3 cells at multiple copy numbers, ensuring a high
level of transgene expression [13, 15]. The cells were ini-
tially selected by puromycin treatment followed by flow
cytometry sorting as described [14]. Expression of mCD47
was confirmed by flow cytometry (Fig. 1b). The newly
established cell lines are designated PC3-mCD47 and
PC3-GFP-Luc (the control cell line), respectively.
We further characterized the PC3-mCD47 cells by com-
paring them with PC3-GFP-Luc control cells for their sen-
sitivity to the phagocytic effect of activated macrophages.
To determine the generality of the impact from mCD47
overexpression, we included in this experiment another
tumor cell that was similarly transduced with mCD47 but
is from different tissue origin. HCT116 is a human colon
cancer cell line and it was transduced with the same trans-
poson constructs to establish HCT116-mCD47 and
HCT116-GFP-Luc. The tumor cells were mixed with acti-
vated macrophages and, as all the tumor cells express lucif-
erase, their viability was conveniently determined by
measuring intracellular luciferase activity after the cells
were extensively washed. The results show that the viability
of both PC3-mCD47 and HCT116-mCD47 was signifi-
cantly higher than that of their respective control cells
(Fig. 2). These results show that overexpression of mCD47
in human cells can negatively impact the phagocytic effect
of murine macrophages when they encounter each other.
Overexpression of mCD47 only marginally enhances local
tumor growth but greatly increase tumor metastasis to
the sentinel lymph node and distant organs in NSG mice
To compare tumor growth properties, both PC3-GFP-Luc
and PC3-mCD47 cells were implanted subcutaneously to
the right flank of NSG mice. Local tumor growth was
measured every 3 days. The size of PC3-mCD47 tumor
was only marginally bigger than that of PC3-GFP-Luc in
NSG mice (Fig. 3a). The local tumors were then surgically
removed to allow the monitoring of tumor cell metastasis
to the sentinel lymph node and distant organs by IVIS
optical imaging. The image signal (radiance in p/s unit)
became detectable at week 3 in mice implanted with PC3-
mCD47 cells, mainly in the body area that covers the
draining lymph node and some distant organs including
lung and liver (Fig. 3b). The radiance then got increasingly
stronger, and by week 4, it reached to an extremely high
level while the radiance in mice planted with PC3-GFP-
Luc was only barely detectable. The experiment was ter-
minated at this point, and the draining lymph node, lung
and liver were collected. The sentinel lymph nodes in
mice implanted with PC3-mCD47 cells were vastly en-
larged. Their average size is 4 times larger than that in
mice implanted with PC3-GFP-Luc cells (Fig. 3c). Micro-
scopic examination of the sections prepared from the col-
lected lung and liver revealed significantly more and larger
metastatic lesions in mice implanted with PC3-mCD47
cells than in the PC3-GFP-Luc group (Fig. 3d and e).
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These data demonstrate that, although overexpression of
mCD47 in PC-3 cells only marginally enhances the estab-
lishment of local tumors, it significantly potentates the
spontaneous metastasis of tumor cells to the sentinel
lymph node and distant organs including lung and liver.
mCD47 also increases metastatic potential of PC-3 cells in
NOD.Scid mice following orthotopic implantation
Due to the presence of additional IL2 receptor gamma
chain deletion, the immunodeficiency in NSG mouse was
significantly more severe than that of NOD.Scid mouse
[16]. Consequently, some human tumor cells show an im-
proved metastatic potential in NSG mouse [17]. Thus, it is
desirable to determine if PC3-mCD47 cells also have an
increased metastatic property in the less immunodeficient
NOD.Scid mice. Additionally, it is also important to deter-
mine if the enhanced metastatic property of PC3-mCD47
cells could be recapitulated following orthotopic route of
implantation. As such, we implanted both PC3-GFP-Luc
and PC3-mCD47 cells intraprostatically into the NOD.S-
cid mice. We also added an additional group of animals in
which the more metastatic PC-3-LN4 cells were im-
planted by the same orthotopic route so that the meta-
static outcome could be compared among the different
groups. Bioluminescent imaging was done weekly on mice
implanted with PC3-mCD47 and PC3-GFPLuc cells to
monitor and confirm tumor growth at the orthotopic site
(data not shown). Mice were euthanized five weeks after
the orthotopic tumor cell implantation and lungs and liver
were harvested. Following H&E staining, the metastatic le-
sions were enumerated as in Fig. 3d. The results show that
animals orthotopically implanted with PC3-mCD47 cells
had 2.5- and 3-fold more pulmonary lesions than the mice
implanted with PC3-GFP-Luc and PC-3 M-LN4 cells, re-
spectively (Fig. 4a). The same metastatic trend was de-
tected in the liver, with mice in the PC3-mCD47 group
having 3- and 4-fold more hepatic lesions than mice in
PC3-GFP-Luc and PC-3 M-LN4 group, respectively
(Fig. 4b). Interestingly, our data also showed that PC-3 M-
LN4 cells were not significantly more metastatic than
PC3-GFP-Luc cells after orthotopic implantation, which is
in line with the observation made by other groups [3]. To-
gether, these data suggest that PC3-mCD47 cells have a
superior ability to spontaneously metastasize to distant
organ tissues than the control PC3-GFP-Luc cells as well
as the selected metastatic PC-3 M-LN4 cells following
orthotopic implantation.
mCD47 promotes spontaneous metastasis in CB17.Scid
mouse in which the parental cells fail to metastasize
Although mCD47 was found to enhance metastases of
PC-3 cells to the distant organs in both NSG and NOD.S-
cid mice after subcutaneous or orthotopic implantation,
the control PC3-GFP-Luc cells showed metastases to these
organs as well albeit at a significantly lower efficiency
(Figs. 3 and 4). It has been reported that CB17.Scid mouse
was significantly less permissive than NOD.Scid in sup-
porting the engraftment of human hematopoietic stem
cells [18, 19]. One of the reasons for the difference on this
permissiveness is that, due to the SIRPα polymorphism
among different mouse strains, SIRPα in Balb/c genetic
background (from which CB17.Scid is derived) has a much
lower binding affinity than its counterpart in C57BL/6
(from which NOD.Scid is derived) to human CD47 [19].
As such, we also implanted both PC3-mCD47 and PC3-
GFP-Luc cells subcutaneously to CB17.Scid mice to
Fig. 2 In vitro assay on phagocytic effect of activated macrophages against human tumor cells with or without mCD47 expression. Activated
RAW 264.7 mouse macrophages were co-cultured with either PC3-mCD47 and PC3-GFP-Luc cell pair (a) or HCT116-mCD47 and HCT116-GFP-Luc
cell pair (b). Tumor cell viability was determined by measuring intracellular luciferase activity and was presented as relative light unit (RLU). Cancer
cells without macrophages co-culturing (the last column of each figure) were used as a positive control and macrophages without tumor cells
were used as the negative control for the assay. Bars represent means plus standard deviations for two experiments, each with duplicate samples.
✱p < 0.05 as compared to the respective GFP-Luc control cells
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compare the local tumor growth as well as migration
to the draining lymph nodes and metastasis to the dis-
tant organs. The results show that, unlike in NSG and
NOD-Scid mice, the control PC3-GFP-Luc cells com-
pletely failed to migrate to the draining lymph node
and to metastasize to either lung or liver (Fig. 5b and
c). Expression of mCD47 moderately enhanced local
tumor growth (Fig. 5a) but significantly potentiated the
tumor cell migration to the draining lymph node
(Fig. 5b) and distant metastasis to the lung (Fig. 5c).
Liver metastasis was detected in the mice from PC3-
mCD47 group, but at a low frequency. These data
demonstrate that mCD47 expression could enable PC-
3 tumor cells to initiate spontaneous local and distant
metastasis in a mouse strain in which otherwise the
tumor cells would not be able to metastasize.
Fig. 3 Local tumor growth and metastasis to the draining lymph node, lung and liver in NSG mice. 2 × 106 PC3-mCD47 and PC3-GFP-Luc cells
were injected to the right flank of NSG mice and tumor growth was monitored for 24 days a. Then primary tumor was surgically removed and
animals were optically imaged weekly with IVIS for luciferase. The signal detected within the region of interest (indicated with a red circle) covers
the draining lymph node and other distant organs such as lung and liver b. Shown on the right-hand side of B are typical images from each
animal group, in which the original tumor inoculation sites were indicated by arrows. The draining lymph node was collected and measured four
weeks later after termination of the experiment c. Shown on the right-hand side of C are representative gross appearances of the explanted
draining lymph nodes. d By the end of the experiment, mice were euthanized and lung and liver were collected for preparation of tissue sections,
which were then H&E stained for histological examination and quantitation of metastatic lesions. The number of metastatic lesions was obtained
from counting five different fields of organ sections from each animal. e shows representative micrographs from the H&E stained lung and liver
tissue. Low magnification showing the entire organ section is on the left of each panel, and high magnification of the defined square area showing
metastatic lesions is on the right of each panel. The metastatic lesions are indicated with arrowheads. Error bars represent the mean ± SD (n = 5 per
group), ✱p < 0.05 and ✜ p < 0.01 as compared to PC3-GFP-Luc
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Discussion
Lack of reliable and efficient metastatic xenograft cancer
models is hampering the progress of many preclinical stud-
ies, particularly for the purpose of drug evaluation. In this
study, we have examined the effect of overexpressing mur-
ine CD47 on the metastatic potential of a widely used hu-
man pancreatic cell line. This study was partly prompted by
the recent demonstration that CD47 is a key “don’t eat me”
signal, as masking CD47 on tumor cells with monoclonal
antibodies allow macrophages to efficiently clear the malig-
nant cells [9]. As human CD47 does not cross react with
murine SIRPα and macrophages in most immunodeficient
mice remain largely intact [20], we reasoned that lack of
engagement of CD47- SIRPα might be a contributing factor
for the low metastatic potential of many xenografted tu-
mors. Our data indeed showed that overexpression of
mCD47 in the popular PC-3 human prostatic cancer cell
line could increase the tumor cell metastasis to the distant
organs such as the lung and liver after the tumor cells were
implanted either subcutaneously or orthotopically. In fact,
under direct comparison, PC3-mCD47 cells produced a
significantly more spontaneous metastasis to the distant
organs of lung and liver than the well-established metastatic
subline PC-3 M-LN4 in NOD.Scid mice, after both cells
were orthotopically implanted. Moreover, mCD47 expres-
sion enables PC-3 tumor cells to initiate spontaneous local
and distant metastasis in a mouse strain (CB17.Scid) that
otherwise is resistant to the metastasis of the tumor cell. As
such, in addition to support the notion that proper engage-
ment of CD47 and SIRPα is important for establishment of
metastatic tumors, this study also suggests that PC3-
mCD47 cells may represent a better metastatic model than
PC-3 M-LN4 for preclinical investigations.
The conclusion drawn from this study is well supported
by the literature. First, Willingham et al have evaluated
CD47 expression on dissociated patient ovarian, breast,
colon, bladder, glioblastoma, hepatocellular carcinoma,
and prostate tumor cells. Their results show that CD47 is
detected at an elevated level on nearly all these cancer cells
[9]. The same study also demonstrates that CD47 mRNA
expression levels predict patient survival. More specifically,
PC-3 cells have been found to overexpress CD47 [21]. Sec-
ond, studies by Ide et al have shown that the interspecies
incompatibility of CD47 contributes to the rejection of
xenogeneic cells by macrophages [22]. Third, other studies
have shown that there is an extensive crosstalk between
colon cancer cells and macrophages and that CD47 pro-
motes tumor cell migration [23]. Finally, studies in com-
bination with clinical data have shown that overexpression
of CD47 on circulating tumor cells correlates with dismal
survival and increased metastasis in a small cohort of
metastatic luminal breast cancer patients [24, 25]. Our
study is the first direct demonstration that overexpression
of murine CD47 in human cancer cells can potentiate the
metastatic potential of the tumor cells in the murine
model. Although we only tested this in a single cell line,
we believe that this principle can be applied to other com-
monly used popular human tumor cell lines.
We conducted the experiments in three mouse strains
with different genetic background and varying degrees of
immunodeficiency. NSG mouse contains all the im-
munodeficiency features of NOD.Scid and CB17.Scid
with additional deletion in IL-2 gamma chain. As a con-
sequence, all the mouse strains share the immunodefi-
ciency of lacking T and B cells, with the major difference
Fig. 4 Distant metastasis after orthotopic implantation of tumor cells
in NOD.Scid mice. PC3-mCD47, PC3-GFP-Luc and PC-3 M-LN4 cells
were orthotopically implanted to the prostates of male NOD.Scid
mice and orthotopic tumor formation in the former two groups was
monitored and confirmed by weekly bioluminescent imaging (data
not shown here). Five weeks after tumor cell implantation, mice
were euthanized. Lungs (a) and livers (b) were collected and were
initially imaged for luciferase signal intensity before they were
sectioned and H&E stained for microscopic detection of metastatic
lesions as described in Fig. 3d. The luciferase images were presented
underneath the corresponding column in each figure. ✱p < 0.05 as
compared to the other two groups
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Fig. 5 Comparison of local tumor growth and distant metastasis in CB17.Scid mice. PC3-mCD47 and PC3-GFP-Luc cells were implanted subcutaneously
to the right flank of CB17.Scid mice. Tumor growth was measured periodically for four weeks (a) before the tumors were excised. Then the animals were
imaged weekly for bioluminescent signal (b) for six weeks before they were euthanized for collection of lungs and livers. Shown on the right-hand side
of B are typical images from each animal group. Metastatic lesions in the lung and liver were determined by microscopic examination of H&E stained
tissue sections (c). ✱p < 0.05 as compared to PC3-GFP-Luc
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being that NSG mouse also lacks functional NK cells [16].
Our data show that overexpression of murine CD47 po-
tentiates the metastatic potential of PC-3 cells to a similar
extent in all the three mouse strains, suggesting that mac-
rophages probably play a more important role than NK
cells in dictating the metastatic potential of PC-3 cells.
NSG and NOD.Scid mice share the same C57BL/6 gen-
etic background. CB17.Scid, on the other hand, is derived
from Balb/c and thus has a different genetic background
as the other two. Studies have shown that murine SIRPα
receptor from mouse strains with C57BL/6 genetic back-
ground can bind to human CD47 to a certain extent, while
SIRPα from mice with Balb/c genetic background has very
weak or no binding affinity to human CD47 [19]. This
may have partly explained our observation that the con-
trol PC3-GFP-Luc cells showed a measurable metastasis
in both NSG and NOD.Scid mice but completely failed to
metastasize in CB17.Scid mice. This is despite the fact that
CB17.Scid and NOD.Scid share a similar degree of im-
munodeficiency. The demonstration that mCD47 enables
PC-3 tumor cells to initiate spontaneous local and distant
metastasis in CB17.Scid mouse that otherwise is resistant
to the metastasis of the tumor cell reinforces the notion
that CD47-SIRPα mediated action of macrophage prob-
ably plays a more important role than other innate im-
mune components in determining the metastatic potential
of xenograft tumors.
Conclusions
In conclusion, we provide evidence that proper engage-
ment of CD47 with its receptor SIRPα is crucial for suc-
cessful establishment of tumor metastases. Specifically,
overexpression of murine CD47 can profoundly enhance
the metastatic potential of human tumor cells in the
xenografted tumor models. Due to the vastly improved
metastatic potential, these established cell lines should
be useful for preclinical studies in where a reliable and
spontaneous metastatic tumor is desirable.
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